Philip D. Walson

4.6k total citations
147 papers, 3.3k citations indexed

About

Philip D. Walson is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Pharmacology. According to data from OpenAlex, Philip D. Walson has authored 147 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pediatrics, Perinatology and Child Health, 25 papers in Surgery and 18 papers in Pharmacology. Recurrent topics in Philip D. Walson's work include Pharmaceutical studies and practices (31 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Epilepsy research and treatment (15 papers). Philip D. Walson is often cited by papers focused on Pharmaceutical studies and practices (31 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Epilepsy research and treatment (15 papers). Philip D. Walson collaborates with scholars based in United States, Germany and Canada. Philip D. Walson's co-authors include Michael Oellerich, Julia Beck, Ekkehard Schütz, Philipp Kanzow, Lawrence E. Leguire, Mary Ellen Mortensen, Don L. Bremer, Gary L. Rogers, Shareen Cox and Mary Lou McGregor and has published in prestigious journals such as JAMA, Neurology and PEDIATRICS.

In The Last Decade

Philip D. Walson

141 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip D. Walson United States 33 678 668 578 459 447 147 3.3k
Philippe Lechat France 42 512 0.8× 952 1.4× 276 0.5× 806 1.8× 389 0.9× 168 7.3k
Andreas Kribben Germany 44 237 0.3× 1.1k 1.6× 472 0.8× 1.0k 2.3× 781 1.7× 293 6.8k
Éric Bellissant France 37 390 0.6× 1.1k 1.6× 344 0.6× 570 1.2× 2.4k 5.3× 183 6.7k
Mary F. Hébert United States 45 2.5k 3.8× 872 1.3× 1.1k 2.0× 523 1.1× 588 1.3× 118 6.4k
Robert Balshaw Canada 31 163 0.2× 795 1.2× 777 1.3× 571 1.2× 825 1.8× 146 3.5k
James J. Lipsky United States 34 330 0.5× 821 1.2× 131 0.2× 1.1k 2.3× 866 1.9× 93 6.7k
Birgit C. P. Koch Netherlands 33 753 1.1× 276 0.4× 240 0.4× 495 1.1× 906 2.0× 272 4.4k
Vassilios Liakopoulos Greece 40 300 0.4× 1.0k 1.6× 87 0.2× 1.0k 2.2× 793 1.8× 382 6.6k
Donald R. A. Uges Netherlands 39 459 0.7× 418 0.6× 149 0.3× 944 2.1× 542 1.2× 143 4.2k
Heiner K. Berthold Germany 37 332 0.5× 1.3k 2.0× 61 0.1× 901 2.0× 794 1.8× 182 6.6k

Countries citing papers authored by Philip D. Walson

Since Specialization
Citations

This map shows the geographic impact of Philip D. Walson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Walson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Walson more than expected).

Fields of papers citing papers by Philip D. Walson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Walson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Walson. The network helps show where Philip D. Walson may publish in the future.

Co-authorship network of co-authors of Philip D. Walson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Walson. A scholar is included among the top collaborators of Philip D. Walson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Walson. Philip D. Walson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rose, Klaus & Philip D. Walson. (2017). Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?. Pediatric Drugs. 19(6). 515–522. 9 indexed citations
2.
Schütz, Ekkehard, Anna Fischer, Julia Beck, et al.. (2017). Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Medicine. 14(4). e1002286–e1002286. 148 indexed citations
3.
Oellerich, Michael, Philipp Kanzow, & Philip D. Walson. (2017). Therapeutic drug monitoring – Key to personalized pharmacotherapy. Clinical Biochemistry. 50(7-8). 375–379. 17 indexed citations
4.
Rose, Klaus & Philip D. Walson. (2017). Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?. Clinical Therapeutics. 39(2). 253–265. 7 indexed citations
5.
Alwahsh, Salamah Mohammad, Драга Тончева, Svilen Maslyankov, et al.. (2013). FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue. Clinical Biochemistry. 47(3). 201–205. 9 indexed citations
6.
Streit, Frank, Lutz Binder, Gunnar Brandhorst, et al.. (2011). Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients. Therapeutic Drug Monitoring. 33(5). 632–643. 21 indexed citations
7.
Nakhla, Meranda, Andrew Denker, James D. Connor, et al.. (2011). Bioavailability and Short-Term Tolerability of Alendronate in Glucocorticoid-Treated Children. Clinical Therapeutics. 33(10). 1516–1523. 10 indexed citations
8.
9.
Walson, Philip D., et al.. (2006). Requirements for publication of Postmarketing studies in clinical therapeutics. Clinical Therapeutics. 28(5). 631–632.
10.
Boni, Joseph, Joan Korth‐Bradley, Patrick Martin, et al.. (1999). Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis. Clinical Therapeutics. 21(10). 1715–1724. 14 indexed citations
11.
Wells, Thomas G., Mary Ellen Mortensen, Ann Dietrich, et al.. (1994). Comparison of the Pharmacokinetics of Naproxen Tablets and Suspension in Children. The Journal of Clinical Pharmacology. 34(1). 30–33. 10 indexed citations
12.
Mortensen, Mary Ellen & Philip D. Walson. (1993). Chelation Therapy for Childhood Lead Poisoning. Clinical Pediatrics. 32(5). 284–291. 17 indexed citations
13.
Wang, Li, et al.. (1993). Antiepileptic effect of antiepilepsirine in pentylenetetrazol and amygdala kindled rats. Epilepsy Research. 15(1). 1–5. 7 indexed citations
14.
Walson, Philip D., et al.. (1993). Acetaminophen Hepatotoxicity After a Prolonged Ingestion. PEDIATRICS. 91(5). 1021–1022. 3 indexed citations
15.
Walson, Philip D., et al.. (1992). Patient-Controlled versus Conventional Analgesia for Postsurgical Pain Relief in Adolescents. Developmental Pharmacology and Therapeutics. 19(1). 32–39. 21 indexed citations
16.
Walson, Philip D., et al.. (1984). Mercury toxicity following merthiolate ear irrigations. The Journal of Pediatrics. 104(2). 311–313. 30 indexed citations
17.
Blanchard, James, et al.. (1984). Factors influencing the transfer of xanthines across the everted rat jejunum. International Journal of Pharmaceutics. 18(3). 259–268. 6 indexed citations
18.
Vaucher, Yvonne E., Philip D. Walson, & Grant Morrow. (1982). Continuous Insulin Infusion in Hyperglycemic, Very Low Birth Weight Infants. Journal of Pediatric Gastroenterology and Nutrition. 1(2). 211–218. 3 indexed citations
19.
Udall, John N., Gail G. Harrison, Yvonne E. Vaucher, Philip D. Walson, & Grant Morrow. (1978). Interaction of Maternal and Neonatal Obesity. PEDIATRICS. 62(1). 17–21. 25 indexed citations
20.
Walson, Philip D., Robert C. Strunk, & Lynn M. Taussig. (1977). Intrapatient variability in theophylline kinetics. The Journal of Pediatrics. 91(2). 321–324. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Lechat Breakdown of academic impact, for papers by Andreas Kribben Breakdown of academic impact, for papers by Éric Bellissant Breakdown of academic impact, for papers by Mary F. Hébert Breakdown of academic impact, for papers by Robert Balshaw Breakdown of academic impact, for papers by James J. Lipsky Breakdown of academic impact, for papers by Birgit C. P. Koch Breakdown of academic impact, for papers by Vassilios Liakopoulos Breakdown of academic impact, for papers by Donald R. A. Uges Breakdown of academic impact, for papers by Heiner K. Berthold
Rankless by CCL
2026